The Role of K ACh Channels in Atrial Fibrillation.
Vadim MitrokhinNikola Hadzi-PetrushevViktor KazanskiStanislav SchileykoOlga KamkinaAnastasija RodinaAlexandra ZolotarevaValentin ZolotarevAndre KamkinMitko I MladenovPublished in: Cells (2024)
This manuscript explores the intricate role of acetylcholine-activated inward rectifier potassium (K ACh ) channels in the pathogenesis of atrial fibrillation (AF), a common cardiac arrhythmia. It delves into the molecular and cellular mechanisms that underpin AF, emphasizing the vital function of K ACh channels in modulating the atrial action potential and facilitating arrhythmogenic conditions. This study underscores the dual nature of K ACh activation and its genetic regulation, revealing that specific variations in potassium channel genes, such as Kir3.4 and K 2P 3.1, significantly influence the electrophysiological remodeling associated with AF. Furthermore, this manuscript identifies the crucial role of the K ACh -mediated current, I KACh , in sustaining arrhythmia through facilitating shorter re-entry circuits and stabilizing the re-entrant circuits, particularly in response to vagal nerve stimulation. Experimental findings from animal models, which could not induce AF in the absence of muscarinic activation, highlight the dependency of AF induction on K ACh channel activity. This is complemented by discussions on therapeutic interventions, where K ACh channel blockers have shown promise in AF management. Additionally, this study discusses the broader implications of K ACh channel behavior, including its ubiquitous presence across different cardiac regions and species, contributing to a comprehensive understanding of AF dynamics. The implications of these findings are profound, suggesting that targeting K ACh channels might offer new therapeutic avenues for AF treatment, particularly in cases resistant to conventional approaches. By integrating genetic, cellular, and pharmacological perspectives, this manuscript offers a holistic view of the potential mechanisms and therapeutic targets in AF, making a significant contribution to the field of cardiac arrhythmia research.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- genome wide
- heart failure
- percutaneous coronary intervention
- coronary artery disease
- physical activity
- single molecule
- mitral valve
- risk assessment
- copy number
- replacement therapy
- venous thromboembolism
- angiotensin converting enzyme
- genome wide analysis